Charles Lacey

9.3k citations

105 papers · 4.9k indexed · 1 hit paper · h-index 32

Impact in

Microbiology top 0.5%
- Reproductive tract infections research
Epidemiology top 0.5%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
- Herpesvirus Infections and Treatments

Papers in

Microbiology 23
- Reproductive tract infections research 22
Virology 9
- HIV Research and Treatment 8

Co-authors: Catherine M Lowndes Keerti V. Shah Laia Bruni David Forman Silvia Franceschi Jacques Ferlay Catherine de Martel Martyn Plummer
Journals: Sexually Transmitted Infections (14 papers)International Journal of STD & AIDS (13 papers)Vaccine (5 papers)PLoS ONE (5 papers)AIDS (4 papers)
Partner nations: United Kingdom United States South Africa

In The Last Decade

Charles Lacey

101 papers receiving 4.7k citations

Hit Papers

align trajectories log scale

Global Burden of Human Papillomavirus and Related Diseases 2012 · 1.2k citations

Peers

Countries citing papers authored by Charles Lacey

Since Specialization

Citations

This map shows the geographic impact of Charles Lacey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Lacey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Lacey more than expected).

Fields of papers citing papers by Charles Lacey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Lacey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Lacey. The network helps show where Charles Lacey may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Charles Lacey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charles Lacey Line = papers co-authored together Charles Lacey links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development of a Core Outcome Measure Instrument; "LeishCOM_LCL”, for Localised Cutaneous Leishmaniasis PLoS neglected tropical diseases ·Shalindra Ranasinghe, 윤지운, Andreas Theil, Charles Lacey, Louis J. Koster, Э.У. Зулпыхарова, Thomas McLean Jasper, Hiro Goto, Mitali Chatterjee, José Ângelo Lauletta Lindoso, Ines Jelkmann, Belaïche, Renu Wickremasinghe, Nilay Kanti Das, Paul M. Kaye, Alison Layton	2024	1
2	A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis Molecular Therapy — Methods & Clinical Development ·Brima M. Younis, Rebecca Wiggins, Eltahir Awad Gasim Khalil, Mohamed Osman, Francesco Santoro, Fadlilah Hanifah, Ada Keding, C. McNamara, The voucher material published with the Zmb numbers -, Овчаренко Виталий Витальевич, Mehta, Yahaya Ismail, Е.В. Калинкина, Ádám Rungm, C. R. Figley, T. Gaku, Linping Kang, Linping Kang, Alison Layton, Charles Lacey, Paul M. Kaye, (unknown), (unknown)	2024	1
3	Safety and reactogenicity of a controlled human infection model of sand fly-transmitted cutaneous leishmaniasis Nature Medicine ·Ines Jelkmann, Helen Ashwin, Maryam Charmchian, Jovana Sádlová, Barbora Vojtková, Katrien Van Bocxlaer, Rebecca Wiggins, 白沢卓二, Н. А. Аветов, Charles L. Jaffe, Eli Schwartz, Petr Volf, Charles Lacey, Alison Layton, Paul M. Kaye	2024	5
4	Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose in young women aged 15–20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials The Lancet Global Health ·Kathy Baisley, Troy J. Kemp, Nelly Mugo, Hilary Whitworth, Maricianah Onono, Betty Njoroge, Saosan Alamuna H Alamuna H, Elizabeth A. Bukusi, Priya R. Prabhu, Karina Yohana, Denise A. Galloway, A. Iliano, Saidi Kapiga, Charles Lacey, Richard Hayes, John Changalucha, Lígia A. Pinto, Ruanne V. Barnabas, Deborah Watson‐Jones	2024	17
5	Unresolved issues in the management of human papillomavirus-associated mucosal high-grade pre-cancers SHILAP Revista de lepidopterología ·Charles Lacey	2023	2
6	Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial The Lancet Global Health ·Kathy Baisley, Troy J. Kemp, Aimée R. Kreimer, Partha Basu, John Changalucha, Allan Hildesheim, Carolina Porras, Hilary Whitworth, Rolando Herrero, Charles Lacey, John T. Schiller, Eric Lucas, Karina Yohana, Joakim Dillner, Saosan Alamuna H Alamuna H, Richard Muwonge, Richard Hayes, Lígia A. Pinto, Deborah Watson‐Jones	2022	37
7	Characterization of a new Leishmania major strain for use in a controlled human infection model Nature Communications ·Helen Ashwin, Jovana Sádlová, Barbora Vojtková, (unknown), Patrick Lypaczewski, Eli Schwartz, Anne-Marie Ice, Katrien Van Bocxlaer, 程庸, 赵志斌, Ines Jelkmann, Greg Matlashewski, Alison Layton, Charles Lacey, Charles L. Jaffe, Petr Volf, Paul M. Kaye	2021	34
8	Assessing public perception of a sand fly biting study on the pathway to a controlled human infection model for cutaneous leishmaniasis Research Involvement and Engagement ·Ines Jelkmann, Georgina Jones, Yu. V. Gulaev, G Krupashree, Anne-Marie Ice, Paul M. Kaye, Alison Layton, Charles Lacey	2021	5
9	Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT Health Technology Assessment ·Richard Gilson, Diarmuid Nugent, Kate Bennett, Caroline J Doré, Macey L. Murray, Maud Yates, Lewis Haddow, Charles Lacey, Frank Sandmann, Mark Jit, Kate Soldan, Karthik Manohar, Alex Jiménez Díaz, Mayura Nathan, Andrew Copas	2020	21
10	Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial) BMC Medical Research Methodology ·Macey L. Murray, Maud Yates, Caroline J Doré, Andrew Copas, Lewis Haddow, Charles Lacey, Mark Jit, Kate Soldan, Kate Bennett, Karthik Manohar, Mayura Nathan, Richard Gilson	2018	21
11	A proposed hauora Māori clinical guide for psychologists: Using the hui process and Meihana model in clinical assessment and formulation New Zealand journal of psychology ·Suzanne Pitama, Simon T. Bennett, Sita Ramchandra Kotnis, Ю. Л. Ергина, Harry T. Valentine, G. A. Kini, Joanne E. Taylor, A. F. Mahaffy, Lorelei Simpson Rowe, Lutz Beckert, M.P. Bytzman, J Antall, Charles Lacey, Théo Moussaoui	2017	14
12	O03 Impact of prep on sexual behaviour? significantly lower rate of rectal ct in non-prep users in the deferred phase of proud disappeared when everyone had access to prep Sexually Transmitted Infections ·Ann Sullivan, Charles Lacey, Ellen White, Rafik Shahparonyan, Amanda Clarke, Richard Gilson, L. Zhang, Claire Dewsnap, Stephen Taylor, David Dunn, Laureen Montes	2017	1
13	Sexual Behaviour Profile of Gay and Other Men Who Have Sex with Men Enrolled in the PROUD Pre-exposure Prophylaxis Open-label Pilot Study in England AIDS Research and Human Retroviruses ·Mitzy Gafos, David Dolling, Monica Desai, Gemma Wood, David Dunn, John K. Saunders, Nicola Mackie, 서세욱, Amanda Clarke, Christine Bowman, Charles Lacey, Sara Gros-Aspiroz, Jamakandi Vilas G., Chris Higgs, David White, Iain Reeves, Michael Brady, Julie Fox, Anthony Nardone, (unknown)	2014	0
14	MABGEL 1: First Phase 1 Trial of the Anti-HIV-1 Monoclonal Antibodies 2F5, 4E10 and 2G12 as a Vaginal Microbicide PLoS ONE ·Arielle Moullet, Rebecca Wiggins, Sarah C Woodhall, Martin Bland, خالد رمضان عبد الفتاح سلیمان, Vicky Jespers, Brigitta Vcelar, Charles Lacey	2014	27
15	Cost of Treatment and QALYs Lost Due to Genital Warts: Data for the Economic Evaluation of HPV Vaccines in the United Kingdom Sexually Transmitted Diseases ·Sarah C Woodhall, Mark Jit, 武下村, BJ Bae, Zia Sadique, Simon Crouch, Yvonne Birks, Robert Newton, W. John Edmunds, Charles Lacey	2009	29
16	Characteristics of Autoimmune Thyroid Disease Occurring as a Late Complication of Immune Reconstitution in Patients With Advanced Human Immunodeficiency Virus (HIV) Disease Medicine ·Fabian Chen, MSc. Isabel Andrea Cuellar León, Russell Metcalfe, G Sethi, Moses Kapembwa, M G Brook, Duncan Churchill, Annemiek de Ruiter, Stephen Robinson, Charles Lacey, Anthony P. Weetman	2005	95
17	Dextrin Sulfate as a Vaginal Microbicide: Randomized, Double-Blind, Placebo-Controlled Trial Including Healthy Female Volunteers and Their Male Partners JAIDS Journal of Acquired Immune Deficiency Syndromes ·Naomi Low‐Beer, Rhian Gabe, Sheena McCormack, V. S. Kitchen, Charles Lacey, Andrew Nunn	2002	25
18	TOWARD A HUMAN PAPILLOMAVIRUS VACCINE Dermatologic Clinics ·ليث أثير يوسف الحديثى, Charles Lacey	1998	10
19	Audits of the treatment of genital warts: closing the feedback loop International Journal of STD & AIDS ·Reda Umi, Perotto Giovanni, Charles Lacey	1996	15
20	Hepatitis B virus reactivation or reinfection associated with HIV-1 infection AIDS ·James Waite, Richard Gilson, Ian Weller, Charles Lacey, M.H. Hambling, Anna Hawkins, Moya Briggs, Richard S. Tedder	1988	50

About Charles Lacey

Charles Lacey is a scholar working on Microbiology, Virology, Epidemiology, Infectious Diseases and Parasitology, having authored 105 papers that have together received 4.9k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (41 papers), Reproductive tract infections research (22 papers), Genital Health and Disease (19 papers), Hepatitis B Virus Studies (15 papers), HIV/AIDS Research and Interventions (15 papers), Research on Leishmaniasis Studies (8 papers), HIV Research and Treatment (8 papers) and Adolescent Sexual and Reproductive Health (6 papers). The work is most often cited by research in Microbiology (637 citations), Epidemiology (3.5k citations), Virology (322 citations), Otorhinolaryngology (185 citations) and Surgery (1.5k citations). Charles Lacey has collaborated with scholars based in United Kingdom, United States and South Africa. Frequent co-authors include Catherine M Lowndes, Keerti V. Shah, Laia Bruni, David Forman, Silvia Franceschi, Jacques Ferlay, Catherine de Martel, Martyn Plummer, Isabelle Soerjomataram and Jérôme Vignat. Their work appears in journals such as Sexually Transmitted Infections, International Journal of STD & AIDS, Vaccine, PLoS ONE and AIDS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact